Navigation Links
Researchers reversed the process of memory loss

In medical breakthrough research findings, researchers have been able to reverse the process of memory// loss in mice, which had significant brain degeneration.

Researchers from University of Minnesota had manipulated the genes of the mice so that the mice have a clinical condition very similar to the Alzheimer’s’ disease in humans. Then the researchers used transgene to check the loss of memory. But the research findings showed that the symptoms of memory loss had been reversed and the mice had started regaining the memory they have lost.

Another new findings of the research were the cause of dementia. Previously it was believed that neurofibrillary tangles and amyloid deposits increase in the brain and this leads to brain degeneration and often causes dementia and Alzheimer’s’ disease. But the research results showed that in the mice that had the memory loss process reversed, there were still increase of neurofibrillary tangles, and amyloid deposits. This shows that these are not the cause of dementia at all.

Dementia is a condition where the person is affected by impaired intellectual capability. Some signs of dementia are short-term memory loss, inability to do concrete or abstract reasoning, difficulty in concentration, inappropriate behavior in social situations etc.

Alzheimer’s disease affects the brain cells and slowly destroys them. The main symptoms of the disease are decreasing memory, ability to reason, creative abilities and learning powers. Millions of people all over the world suffer from the two conditions, and the new research findings may make them easier to fit into normal life.

Reference: Science, July 205
'"/>




Page: 1

Related medicine news :

1. Researchers urge caution in using ear tube surgery
2. Researchers Scale to assess the Severity of Epilepsy in Kids
3. Researchers trick Alzheimers Enzyme
4. Researchers find new HIV hiding place
5. New Hair in 15 Days Could Now Be A Possibility Say Researchers
6. Researchers developed world’s smallest toothbrus
7. Researchers discover receptor cells that can cause epilepsy
8. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
9. Researchers Identify Key Gene That May Help Brain Treatment
10. Researchers Discover Protein That Causes Malaria
11. Commercialization of Biotech Discoveries, An Encouragement For Researchers
Post Your Comments:
(Date:5/17/2008)... as guide for avoiding exposure , , SAT...e earrings you bought from a hip young street arti...rs and skin. , A new report finds that many pai... Francisco stores and artists contain nickel, whic...d exposure can make treatment difficult. , The ...
(Date:5/16/2008)...ck; Merger Sets Up Healthy Back as the Nation...N, Va., May 16 /PRNewswire/ -- Healthy Back, the 1...ce back wellness created an,ergonomic revolution, ...JoAnne,s Bed & Back. Healthy Back,s 18 stores and ...lion. JoAnne,s 16 mid-Atlantic stores,claimed annu...
(Date:5/16/2008)...yroid hormone readings, study says , , F...tamin D and high levels of a hormone secreted by t...ression in older adults, according to a new report...e of Archives of General Psychiatry , supports pr...depression and other psychiatric illnesses are lin...
(Date:5/16/2008)...e of Oral and Overall Health, HARRISBURG, Pa., Ma...d,Concordia Dental is celebrating National Smile M...and the British Dental Health Foundation to,promot... Beginning May 18,this year,s event is launching ... the largest independent international dental heal...
Breaking Medicine News(10 mins):Health News:Cheaper Earrings More Likely to Contain Nickel 2Health News:Cheaper Earrings More Likely to Contain Nickel 3Health News:The Back Wars Come to a Close 2Health News:Low Vitamin D Tied to Depression in Older Adults 2Health News:United Concordia Dental Celebrates National Smile Month 2
...handigarh is all set to turn into a "no-smoking zo...horities, the ban would be fully enforced from Jul.... Smoking kills over a million of the 250 million ...country. The establishment says it will not make...
... new study has found that weight management progra...easing weight, body fat, body mass index (BMI) in ...ement program developed by researchers at Yale Sch...at plummeting weight, body fat, BMI and insulin se...
...ndian neuroscientists are part of an international...s of mental retardation and autism in mice, raisi...fects one in 500 children. Researchers at the Nat... (NCBS) and National Institute of Mental Health an...
...learly a new wind is blowing across in three key a... are sick, literally and metaphorically, one might...respective governments seem to have failed the peo...king off a major healthcare crisis. The powers-tha...
Other Medicine News:Health News:Chandigarh Set to Be No-smoking Zone from July 15 2Health News:Bright Bodies Weight Program Lowers Diabetes Risk, BMI in Obese Kids 2Health News:Research Shows Way for Drug Therapy for Autism 2Health News:Back to Basics in Health in Advanced Countries Now 2Health News:Back to Basics in Health in Advanced Countries Now 3Health News:Back to Basics in Health in Advanced Countries Now 4
(Date:5/15/2008)...ITA SPRINGS, Fla., May 15 /- Tigris P... of a Cooperative Research and,Development Agreeme...) to,collaborate on clinical and preclinical devel...ase I development. AFP-464 is converted to,metabol...3 activation and,apoptosis., This is part of a fo...
(Date:5/15/2008)...rable Opportunity Remains for an Antiplatelet Ther...ding than the Combination of Plavix/Iscover an... Resources, WALTHAM, Mass., May 15 /...esearch and advisory firms for pharmaceutical and,...illy,s Effient offers,improvement in patient compa...
(Date:5/15/2008)...ine Data Expected soon after CEA Trial data report... -, SAN FRANCISCO, May 15 /PRNewswire-FirstCall... biotechnology company focused on the development ...isease, announced today that,it has completed pati...),study. The ACS study is one of three Phase 2 tri...
(Date:5/15/2008)...ta Presented at the 21st Annual Meeting of The Ame...ncology (ASPHO) Meeting -, IRVINE, Calif., May 15...ompany) (Nasdaq: IDMI ) today announced the prese...s program evaluating mifamurtide (L-MTP-PE) in,pat...ression of,osteosarcoma, a rare and often fatal bo...
Breaking Medicine Technology:Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 2Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute 3Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 2VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 3VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 4VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 2IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 3IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 4IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 5IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program 6Cyprotex Introduces New Product Line Cloe 28R 29 Select a Portfolio of Bespoke ADME and PK Services 4341 1Cyprotex Introduces New Product Line Cloe 28R 29 Select a Portfolio of Bespoke ADME and PK Services 4341 2Households with kids with autism likely to earn less 15730 1Households with kids with autism likely to earn less 15730 2Households with kids with autism likely to earn less 15730 3Climate and cholera 2713 1CompareNetworks Inc Fuels Growth by Raising Round of Financing 15726 1CompareNetworks Inc Fuels Growth by Raising Round of Financing 15726 2
...h Copaxone Plus Minocycline Showed Substantial,Red...,Relapsing-Remitting Multiple Sclerosis , Combinat...n,Lesions and Was Well Tolerated , KANSAS CITY, Mo...-blind study showed that a combination of Copaxone...l antibiotic,minocycline reduced T1 Gadolinium (Gd...
...o.--(BUSINESS WIRE)--May 4, 2007 - New data from a...ination of,COPAXONE(R) (glatiramer acetate injecti...uced T1 Gadolinium (Gd)-enhancing lesions,of the b...e,relapsing-remitting multiple sclerosis (RRMS), a...mpared to those receiving,COPAXONE(R) alone. Addit...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5
Inquire
Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of Measles IgM antibodies in human serum. For in vitro diagnostic use. High complexity test.
...nzymelinked Immunosorbent Assays(ELISA) is intende... of IgG antibody to Measles Rubeola) virus in huma... the determination of immune status. Paired sera, ...te seroconversion or a significant rise in antibod...
The Diagnostic Automation, Inc. (DAI) Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of IgM antibody to Measles in human serum.
Medicine Products: